|
TBC1D15 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.231560E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.431800E-01 |
| Normal-vs-Stage2 |
7.965000E-01 |
| Normal-vs-Stage3 |
1.003570E-03 |
| Normal-vs-Stage4 |
1.227120E-04 |
| Stage1-vs-Stage2 |
9.552400E-01 |
| Stage1-vs-Stage3 |
6.02349999999641E-05 |
| Stage1-vs-Stage4 |
1.92143999999672E-05 |
| Stage2-vs-Stage3 |
5.888000E-02 |
| Stage2-vs-Stage4 |
2.608300E-02 |
| Stage3-vs-Stage4 |
5.479000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.646400E-01 |
| Normal-vs-AfricanAmerican |
4.961200E-03 |
| Normal-vs-Asian |
2.797600E-01 |
| Caucasian-vs-AfricanAmerican |
2.554300E-02 |
| Caucasian-vs-Asian |
4.889400E-01 |
| AfricanAmerican-vs-Asian |
9.701400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.804300E-02 |
| Normal-vs-Female |
6.509600E-01 |
| Male-vs-Female |
2.270200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.802000E-02 |
| Normal-vs-Age(41-60Yrs) |
7.761800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.055800E-02 |
| Normal-vs-Age(81-100Yrs) |
1.111810E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.526010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.831400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.294800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.658600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.559600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.543200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.898500E-02 |
| Normal-vs-Grade 2 |
1.351960E-01 |
| Normal-vs-Grade 3 |
1.297180E-03 |
| Normal-vs-Grade 4 |
6.07919999895401E-08 |
| Grade 1-vs-Grade 2 |
1.999560E-01 |
| Grade 1-vs-Grade 3 |
5.369100E-04 |
| Grade 1-vs-Grade 4 |
3.95360000005063E-06 |
| Grade 2-vs-Grade 3 |
1.71538000000027E-05 |
| Grade 2-vs-Grade 4 |
6.55190013354456E-10 |
| Grade 3-vs-Grade 4 |
1.702220E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.280150E-03 |
| Normal-vs-ccB subtype |
1.420960E-04 |
| ccA subtype-vs-ccB subtype |
8.66730021087392E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.599200E-01 |
| Normal-vs-N1 |
3.710200E-02 |
| N0-vs-N1 |
9.856100E-02 |
|
|
